Surgery Doctors in Harrison, NY Accepting Medicare

4 Surgery doctors found. Showing 1 - 4

Dr. Chaitan Devulapalli, M.D. Surgery - Plastic and Reconstructive Surgery Medicare: Accepting Medicare Assignments Practice Location: 500 Mamaroneck Ave Ste 211, Harrison, NY 10528 Phone: 914-771-7373    Fax: 914-337-6757

Dr. Nicole Lea Nemeth, MD Surgery - Plastic and Reconstructive Surgery Medicare: May Accept Medicare Assignments Practice Location: 500 Mamaroneck Avenue, Suite 211, Harrison, NY 10528 Phone: 914-771-7373

Dr. Vadim Pisarenko, M.D. Surgery Medicare: May Accept Medicare Assignments Practice Location: 500 Mamaroneck Avenue, Suite 211, Harrison, NY 10528 Phone: 201-546-1729

Dr. Richard Charles Garvey, MD Surgery - Plastic and Reconstructive Surgery Medicare: Medicare Enrolled Practice Location: 500 Mamaroneck Avenue, Suite 211, Harrison, NY 10528 Phone: 914-664-8000

News Archive

FDA Advisory Committee recommends marketing approval for Auxilium's XIAFLEX to treat Dupuytren's contracture

Auxilium Pharmaceuticals, Inc. (NASDAQ: AUXL), a specialty biopharmaceutical company, today announced that the Arthritis Advisory Committee appointed by the U.S. Food and Drug Administration (FDA) recommended by a unanimous vote of 12 to 0 that XIAFLEX™ (collagenase clostridium histolyticum), a novel, first-in-class, orphan-designated, biologic, be granted marketing approval by the FDA for the treatment of Dupuytren's contracture.

New research could advance art therapy for treating neurological and psychiatric disorders

Studies conducted at the University of Vienna by Marie Curie fellow Matthew Pelowski have contributed to the formation of the Vienna Integrated Model of Art Perception, a holistic framework within which the multiple cognitive processes underlying art viewing can be systematically organised.

Researchers discover new pathway that opens door to treat non-alcoholic fatty liver disease

Researchers from the University of South Carolina, Duke University, University of Alabama at Birmingham, and Metabolon Inc. Research Triangle Park have discovered a new pathway in the liver that opens the door to treat non-alcoholic fatty liver disease, a condition that affects up to 25 percent of the population and may lead to cirrhosis and eventually liver cancer or failure, and likely other liver diseases.

New class of drugs hold promise against aggressive forms of pancreatic cancer

Cancer Research UK-funded scientists have shown how a promising new class of drugs might be used to treat aggressive forms of pancreatic cancer, according to a study published in Nature.

Read more Medical News

› Verified 5 days ago